Molecular effects of genistein, as a potential anticancer agent, on CXCR-4 and VEGF pathway in acute lymphoblastic leukemia

被引:0
|
作者
Mohsen Shahmoradi
Fatemeh Banisharif-Dehkordi
Mahnoush kouhihabibidehkordi
Mahdi GhatrehSamani
Mohammad-Saied Jami
Hedayatollah Shirzad
Batoul Pourgheysari
机构
[1] Shahrekord University of Medical Sciences,Cellular and Molecular Research Center, Basic Health Sciences Institute
[2] University of California Los Angeles (UCLA),Department of Neurology, David Geffen School of Medicine
[3] Shahrekord University of Medical Sciences,Medical Plants Research Center, Basic Health Sciences Institute
来源
Molecular Biology Reports | 2022年 / 49卷
关键词
Acute lymphoblastic leukemia; CXCR-4; Genistein; VEGF;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4161 / 4170
页数:9
相关论文
共 50 条
  • [1] Molecular effects of genistein, as a potential anticancer agent, on CXCR-4 and VEGF pathway in acute lymphoblastic leukemia
    Shahmoradi, Mohsen
    Banisharif-Dehkordi, Fatemeh
    Kouhihabibidehkordi, Mahnoush
    GhatrehSamani, Mahdi
    Jami, Mohammad-Saied
    Shirzad, Hedayatollah
    Pourgheysari, Batoul
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (06) : 4161 - 4170
  • [2] Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition
    Sison, Edward Allan R.
    Magoon, Daniel
    Li, Li
    Annesley, Colleen E.
    Rau, Rachel E.
    Small, Donald
    Brown, Patrick
    ONCOTARGET, 2014, 5 (19) : 8947 - 8958
  • [3] Molecular characterization of CXCR-4: A potential brain tumor-associated gene
    Sehgal, A
    Ricks, S
    Boynton, AL
    Warrick, J
    Murphy, GP
    JOURNAL OF SURGICAL ONCOLOGY, 1998, 69 (04) : 239 - 248
  • [4] Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro
    J Juarez
    K F Bradstock
    D J Gottlieb
    L J Bendall
    Leukemia, 2003, 17 : 1294 - 1300
  • [5] Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro
    Juarez, J
    Bradstock, KF
    Gottlieb, DJ
    Bendall, LJ
    LEUKEMIA, 2003, 17 (07) : 1294 - 1300
  • [6] Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression
    Tsaouli, Georgia
    Ferretti, Elisabetta
    Bellavia, Diana
    Vacca, Alessandra
    Felli, Maria Pia
    JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
  • [7] Is high expression of the chemokine receptor CXCR-4 of predictive value for early relapse in childhood acute lymphoblastic leukaemia?
    Schneider, P
    Vasse, M
    Al Bayati, A
    Lenormand, B
    Vannier, JP
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (02) : 579 - 580
  • [8] A FUNDAMENTAL ROLE OF CXCR4 IN T-ACUTE LYMPHOBLASTIC LEUKEMIA
    Passaro, D.
    Irigoyen, M.
    Gachet, S.
    De Jesus, C. Da Costa
    Lasgi, C.
    Quang, C. Tran
    Ghysdael, J.
    HAEMATOLOGICA, 2015, 100 : 329 - 329
  • [9] Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist
    Parameswaran, R.
    Yu, M.
    Lim, M.
    Groffen, J.
    Heisterkamp, N.
    LEUKEMIA, 2011, 25 (08) : 1314 - 1323
  • [10] Lymphoblastic leukemia cells express CXCR-4 and migrate through endothelium in response to SDF-1: Implications for leukemia cell vaccination.
    Cardoso, AA
    Veiga, JP
    Ghia, P
    Afonso, HM
    Nadler, LM
    BLOOD, 1998, 92 (10) : 618A - 618A